Angioedema, hereditary, types I and II

Clinical trials for Angioedema, hereditary, types I and II explained in plain language.

Never miss a new study

Get alerted when new Angioedema, hereditary, types I and II trials appear

Sign up with your email to follow new studies for Angioedema, hereditary, types I and II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New daily pill aims to stop HAE attacks, but trial cut short

Disease control Stopped early

This phase 2 trial tested KVD824, an oral pill, to prevent swelling attacks in people with hereditary angioedema types I and II. The study planned to compare three doses against a placebo over several months. However, the trial was terminated early with only 33 participants, so t…

Matched conditions: ANGIOEDEMA, HEREDITARY, TYPES I AND II

Phase 2 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

Angioedema, hereditary, types I and II

Get alerted when new Angioedema, hereditary, types I and II trials appear

New daily pill aims to stop HAE attacks, but trial cut short